Citation: Ll. Siu et al., PHASE I II STUDY OF THE CAPABLE REGIMEN FOR PATIENTS WITH POORLY DIFFERENTIATED CARCINOMA OF THE NASOPHARYNX/, Journal of clinical oncology, 16(7), 1998, pp. 2514-2521
Citation: Pm. Czaykowski et al., HIGH-RISE OF VASCULAR EVENTS IN PATIENTS WITH UROTHELIAL TRANSITIONAL-CELL CARCINOMA TREATED WITH CISPLATIN-BASED CHEMOTHERAPY, The Journal of urology, 160(6), 1998, pp. 2021-2024
Authors:
MICHAEL M
TANNOCK IF
CZAYKOWSKI PM
MOORE MJ
Citation: M. Michael et al., ADJUVANT CHEMOTHERAPY FOR HIGH-RISK UROTHELIAL TRANSITIONAL-CELL CARCINOMA - THE PRINCESS-MARGARET-HOSPITAL EXPERIENCE, British Journal of Urology, 82(3), 1998, pp. 366-372
Citation: Pm. Czaykowski et al., SALVAGE CHEMOTHERAPY WITH CLADRIBINE IN A PATIENT WITH RECURRENT MALIGNANT OLIGODENDROGLIOMA - A CASE-REPORT, Oncology Reports, 4(4), 1997, pp. 849-851